193 related articles for article (PubMed ID: 16941021)
1. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association.
Lefaucheur C; Stengel B; Nochy D; Martel P; Hill GS; Jacquot C; Rossert J;
Kidney Int; 2006 Oct; 70(8):1510-7. PubMed ID: 16941021
[TBL] [Abstract][Full Text] [Related]
2. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy.
Qu Z; Liu G; Li J; Wu LH; Tan Y; Zheng X; Ao J; Zhao MH
Nephrol Dial Transplant; 2012 May; 27(5):1931-7. PubMed ID: 21976738
[TBL] [Abstract][Full Text] [Related]
3. Long-term risk of cancer in membranous nephropathy patients.
Bjørneklett R; Vikse BE; Svarstad E; Aasarød K; Bostad L; Langmark F; Iversen BM
Am J Kidney Dis; 2007 Sep; 50(3):396-403. PubMed ID: 17720518
[TBL] [Abstract][Full Text] [Related]
4. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O; Watier L; Rossert J; Stengel B;
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[TBL] [Abstract][Full Text] [Related]
5. Cancer development and mortality differences in patients with glomerulonephritis after renal biopsy: a single center retrospective cohort study.
Ryu H; Kim K; Ryu J; Son HE; Ryu JY; Kim S; Na KY; Chae DW; Chin HJ;
BMC Nephrol; 2020 Jun; 21(1):221. PubMed ID: 32522167
[TBL] [Abstract][Full Text] [Related]
6. Membranous nephropathy with crescents: a series of 19 cases.
Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
8. Etiology and clinical characteristics of membranous nephropathy in Chinese patients.
Zeng CH; Chen HM; Wang RS; Chen Y; Zhang SH; Liu L; Li LS; Liu ZH
Am J Kidney Dis; 2008 Oct; 52(4):691-8. PubMed ID: 18805348
[TBL] [Abstract][Full Text] [Related]
9. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B
Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747
[TBL] [Abstract][Full Text] [Related]
10. The clinicopathological implications of endothelial tubuloreticular inclusions found in glomeruli having histopathology of idiopathic membranous nephropathy.
Yang AH; Lin BS; Kuo KL; Chang CC; Ng YY; Yang WC
Nephrol Dial Transplant; 2009 Nov; 24(11):3419-25. PubMed ID: 19535433
[TBL] [Abstract][Full Text] [Related]
11. Crescentic transformation in primary membranous glomerulopathy: association with anti-GBM antibody.
Nayak SG; Satish R
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):599-602. PubMed ID: 17951950
[TBL] [Abstract][Full Text] [Related]
12. Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study.
Dabade TS; Grande JP; Norby SM; Fervenza FC; Cosio FG
Am J Transplant; 2008 Jun; 8(6):1318-22. PubMed ID: 18444918
[TBL] [Abstract][Full Text] [Related]
13. Low glomerular density is a risk factor for progression in idiopathic membranous nephropathy.
Tsuboi N; Kawamura T; Miyazaki Y; Utsunomiya Y; Hosoya T
Nephrol Dial Transplant; 2011 Nov; 26(11):3555-60. PubMed ID: 21771759
[TBL] [Abstract][Full Text] [Related]
14. [Case of MPO-ANCA-associated vasculitis with membranous nephropathy].
Watanabe S; Arimura Y; Nomura K; Kawashima S; Yoshihara K; Kaname S; Yamada A
Nihon Jinzo Gakkai Shi; 2011; 53(1):46-52. PubMed ID: 21370577
[TBL] [Abstract][Full Text] [Related]
15. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.
Terrier B; Delmas Y; Hummel A; Presne C; Glowacki F; Knebelmann B; Combe C; Lesavre P; Maillard N; Noël LH; Patey-Mariaud de Serre N; Nusbaum S; Radford I; Buzyn A; Fakhouri F
Nephrol Dial Transplant; 2007 May; 22(5):1369-76. PubMed ID: 17255123
[TBL] [Abstract][Full Text] [Related]
16. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.
Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H
Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223
[TBL] [Abstract][Full Text] [Related]
17. Membranous nephropathy and malignancy.
Beck LH
Semin Nephrol; 2010 Nov; 30(6):635-44. PubMed ID: 21146128
[TBL] [Abstract][Full Text] [Related]
18. [Paraneoplastic membranous nephropathy].
Romanov VP; Klopotskiĭ SA
Klin Med (Mosk); 2006; 84(6):59-61. PubMed ID: 16875073
[TBL] [Abstract][Full Text] [Related]
19. Does treatment with corticosteroids and cyclosporine reduce transglutaminase type 2 expression in the renal tissue of patients with membranous nephropathy?
Papasotiriou M; Kalliakmani P; Huang L; Gerolymos M; Goumenos DS; Johnson TS
Nephron Clin Pract; 2012; 121(1-2):c60-7. PubMed ID: 23107829
[TBL] [Abstract][Full Text] [Related]
20. [Clinico-pathological study of focal glomerular sclerotic lesions in idiopathic membranous nephropathy].
Iwahashi C
Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):139-43. PubMed ID: 2051640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
